Centre for Inflammatory Disease Monash Health

Research Output 1983 2020

Filter
Abstract

Annexin-1 regulates inflammatory response via glucocorticoid-induced genes

Yang, Y. H., Rao, Z. (ed.), Aeberli, D., Liu, J-P. (ed.), Leech, M. T., Dacumos-Hill, A., Xue, J. R. & Morand, E. F., 2009, p. 200 - 200. 1 p.

Research output: Contribution to conferenceAbstract

Attainment of the lupus low disease activity state is associated with protection from damage accrual in patients with active disease at baseline

Golder, V., Morand, E. F., Kandane-Rathnayake, R., Huq, M., Nim, H., Louthrenoo, W., Luo, S. F., Wu, Y-J., Lateef, A., Sockalingam, S., Navarra, S. T. V., Zamora, L., Hamijoyo, L., Katsumata, Y., Harigai, M., Chan, M., O’Neill, S., Goldblatt, F., Sing Lau, C., Li, Z. & 2 others, Hoi, A. & Nikpour, M., 2019, p. 203-203. 1 p.

Research output: Contribution to conferenceAbstract

Australian interns’ knowledge of hepatitis A, B, C and HIV and occupational exposures.

Vujovic, O. V., Koehler, N., Dendle, C. & McMenamin, C. C., 2012.

Research output: Contribution to conferenceAbstract

AUTOPHAGY REGULATES MIF AND GLUCOCORTICOID SENSITIVITY

Morand, E. F., Fan, H., Lang, T., Foote, A. M., Gavrilescu, N., Lee, J. & Harris, J., May 2015, p. 25.

Research output: Contribution to conferenceAbstract

Comparison of effects of DORIS remission and lupus low disease activity state (LLDAS) on disease outcomes in a multinational prospective study

Morand, E., Golder, V., Kandane-Rathnayake, R., Huq, M., Nim, H., Louthrenoo, W., Luo, S. F., Lateef, A., Sockalingam, S., Navarra, S., Hamijoyo, L., Katsumata, Y., Chan, M., Hoi, A. & Nikpour, M., 2019. 1 p.

Research output: Contribution to conferenceAbstract

Highly purified mouse mesenchymal stem cells exhibit equal potential in non-hematopoietic differentiation and enhanced immunosuppressive ability

Oh, D. Y., McKay, R. D. (ed.), Cui, P., Mosse, J. A., Toh, B-H. & Chan, M. K. J., 2009, p. 252 - 252. 1 p.

Research output: Contribution to conferenceAbstract

Low toxic non-myeloablative regimen as preconditioning for induction of immune tolerance using gene therapy

Nasa, Z., Chung, J., Joglekar, A., Chan, M., Toh, B-H. & Alderuccio, F., 2011, p. 442 - 442. 1 p.

Research output: Contribution to conferenceAbstract

Prospective multicenter validation of the lupus low disease activity state (LLDAS) treatment target

Morand, E., Golder, V., Kandane-Rathnayake, R., Huq, M., Nim, H., Louthrenoo, W., Luo, S. F., Lateef, A., Sockalingam, S., Navarra, S., Hamijoyo, L., Katsumata, Y., Chan, M., Hoi, A. & Nikpour, M., 2019, p. 25. 1 p.

Research output: Contribution to conferenceAbstract

The cost of Trus biopsy-sepsis admissions to Victorian public hospitals over 5 years

Roth, H., Millar, J., Cheng, A., Byrne, A., Evans, S. & Grummet, J., 2016, p. 51. 1 p.

Research output: Contribution to conferenceAbstract

The effects of thrombomodulin on experimental colitis

Lust, M., Moore, G. T. C., Brown, S. J., Bell, S. J., Connell, W. R., Elliott, P. R., Slavin, J. L., Nandurkar, H. H., Cowan, P. J., Desmond, P. V. & D'Apice, A. J. F., 2006, p. A280.

Research output: Contribution to conferenceAbstract

Therapeutic trajectories following high disease activity state in SLE

McMaster, C., Nim, H., Koelmeyer, R., Frauman, A., Morand, E. & Hoi, A. Y., 2019. 1 p.

Research output: Contribution to conferenceAbstract